Christine Geisler

Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer

Cathleen Nientiedt, Jan Budczies, Volker Endris et al. · Urologic Oncology Seminars and Original Investigations · 2021 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17

Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine

Eike Binz, Susanne Berchtold, Julia Beil et al. · Molecular Therapy — Oncolytics · 2017 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko et al. · Nature Communications · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate Cancer

Sebastian Schwarz, Cathleen Nientiedt, Elena‐Sophie Prigge et al. · Pathobiology · 2023 · 10 citations · Full text

Medicine, Oncology, Urology +16